The Irish Cancer Society has criticized Ireland’s two-tier health system, highlighting that public cancer patients face significant delays in accessing life-saving treatments compared to those in private hospitals. According to Dr. Michael McCarthy, public patients wait up to two years for EMA-approved cancer drugs, with 30-40% of new treatments unavailable to them. The society is urging the next government to improve funding for the National Cancer Strategy and streamline access to vital therapies.